Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
notice and comment rulemaking
Notice of Privacy
notice provision
See national provider identifier (NPI) number Health Insurance Portability and Accountability Act of 1996 See national provider identifier (NPI) number
See narrow therapeutic index (NTI) drugs Narrow Therapeutic Index Drugs See narrow therapeutic index (NTI) drugs
See National Technical Information Service (NTIS) See National Technical Information Service (NTIS) Those Allowed to Prescribe Controlled Substances
Nutraceutical Corp. v. Crawford (2005)
Nutraceutical Corp. v. Von Eschenbach (2006)
nutraceuticals
Schweiker (1983) Foods vs Drugs Nutrilab, Inc., et al. v. Schweiker The Lanham Trademark Act
nutritional support statements
Nutrition Labeling and Education Act of 1990 (NLEA) Foods vs Drugs Medical Device User Fee and Modernization Act of 2002
NVE, Inc. v. Department of Health and Human Services (2006)
See Omnibus Budget Reconciliation Act of 1990 (OBRA '90) Basic Framework of OBRA ‘90 Components of Prospective Drug Use Review Federal Regulation of Pharmacy Practice Preface Rationale for Expanded Pharmacist Duties See Omnibus Budget Reconciliation Act of 1990 (OBRA '90) The Omnibus Budget Reconciliation Act of 1990
Occupational Safety and Health Act
Occupational Safety and Health Administration (OCSHA)
See Office for Civil Rights (OCR) Health Information Technology Infrastructure Health Insurance Portability and Accountability Act of 1996 Penalties and Enforcement See Office for Civil Rights (OCR) Use and Disclosure of PHI; Right to Access
Odell v. Axelrod (1984)
Office for Civil Rights (OCR)
Office of Inspector General (OIG)
Office of Prescription Drug Promotion
Office of the National Coordinator for HIT (ONCHIT)
off-label (unlabeled) indications, approved drugs for
off-label use of medication advertising and promotion Heckler V. Chaney (1984) - Heckler V. Chaney Ramon V. Farr (1989) - Ramon V. Farr
See Office of Inspector General (OIG) 340B Drugs Actions Against a License Anti-Kickback Statute Medicare Part D Overview of Important Developments in Medicaid and Prescription Drug Reimbursement Prescription Drug Advertising: Manufacturer to Professionals See Office of Inspector General (OIG)
OIG Compliance Program Guidance for Pharmaceutical Manufacturers
Omnibus Budget Reconciliation Act of 1990 (OBRA '90)
Omnibus Budget Reconciliation Act of 1990 (OBRA ‘90) drug utilization review (DUR) off-label uses of medications overview standards of practice State Regulation of Third-Party Plans The Omnibus Budget Reconciliation Act of 1990
online pharmacies
opiate dependence